NOCION THERAPEUTICS
Live / Applied — Statement of use — processing complete, to examiner (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 09 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98490184
- Mark type
- Stylized text
- Filed
- 09 Apr 2024
- Published for opposition
- 14 Jan 2025
- Attorney of record
- Erica L. Han
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for peripheral nervous system; pharmaceutical agents affecting peripheral nervous system; biological preparations for the treatment of peripheral nervous system disorders
Owner
- Nocion Therapeutics, Inc., Watertown, MA, US
- Nocion Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 20 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Sept 2025 — USE AMENDMENT FILED
- 19 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Dec 2024 — EXAMINER'S AMENDMENT ENTERED
- 17 Dec 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Dec 2024 — EXAMINERS AMENDMENT E-MAILED
- 17 Dec 2024 — EXAMINERS AMENDMENT -WRITTEN
- 15 Dec 2024 — ASSIGNED TO EXAMINER
- 14 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED